This page includes a range of resources and training materials you may find useful to help manage your patients' treatment journey. The content below includes downloadable resources covering dosing and infusion, administration steps, and AR management.
You will also find tools for patient and payment support, an archive of HCP resources, and a link to get in touch with an Oncology Clinical Educator.
Resources for your practice
First-line EGFR+ Treatment Management Reference Cards
Dosage & Administration Reference Card
Contains dosing schedule and administration information for RYBREVANT® + LAZCLUZE™.
Proactive Supportive Care Reference Card
Provides guideline recommendations and tips for proactively managing dermatologic ARs for RYBREVANT® + LAZCLUZE™.
IRR Monitoring & Management Reference Card
Includes information on IRR monitoring and management, including premedications and recommended dose modifications for RYBREVANT®.
Adverse Reaction Monitoring & Management Reference Card
Contains information on key ARs and dose modification guidance for RYBREVANT® + LAZCLUZE™.
HCP resources
Information for dosing and administration for RYBREVANT® and proactive supportive care guidance for ARs.
Access resources for your practice
Information for access, affordability, and treatment support program from Johnson & Johnson.
Patient Resources
Download to support your patients with their treatment experience.
Once you have made the clinical decision to prescribe a RYBREVANT® regimen, Johnson & Johnson has resouces to help you support your patients.
Get in touch with an OCE (Oncology Clinical Educator)
Our team of Oncology Clinical Educators (OCEs) are oncology nurses employed by Johnson & Johnson and trained to provide product and disease education information to oncology patient-care team members, patient support groups, and advocacy organizations.